FCM
DXCM icon

Fieldview Capital Management’s DexCom DXCM Stock Holding History

Fieldview Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,822
Closed -$453K – 549
2025
Q4 		$453K Buy
+6,822
New +$441K 0.08% 290
2025
Q3 		– Sell
-17,756
Closed -$1.55M – 427
2025
Q2 		$1.55M Buy
+17,756
New +$1.39M 0.23% 152

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fieldview Capital Management's DXCM Position: Q1 2026 in Review

Fieldview Capital Management sold out of DexCom (DXCM) in Q1 2026, closing a stake of 6,822 shares — an estimated $453K sold.

Fieldview Capital Management first reported a position in DXCM in Q2 2025 and held it in 2 quarters. The position peaked at $1.55M in Q2 2025. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Fieldview Capital Management reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Fieldview Capital Management sold 6,822 DexCom shares in Q1 2026, an estimated $453K.
  • Fieldview Capital Management first reported a position in DexCom in Q2 2025 and held it in 2 quarters.
  • Fieldview Capital Management's DexCom position peaked at $1.55M in Q2 2025.
  • 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Fieldview Capital Management's 13F filing for Q1 2026, filed 14 May 2026.